U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Royal Wine Corporation - 449249 - 10/31/2017
  1. Warning Letters

CLOSEOUT LETTER

Royal Wine Corporation MARCS-CMS 449249 —

Recipient:
Royal Wine Corporation

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

Office of Human and Animal Food Operations East
Division 1
 
 

October 31, 2017

Mr. Michael B. Herzog, Owner
Royal Wine Corporation
1519 Route 9W
Marlboro, NY 12542

Dear Mr. Herzog:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter [NYK 2015-38, June 10, 2015]. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

CDR Catherine Beer
Acting Director, Compliance Branch
Office of Human and Animal Food Operations East – Division 1

Back to Top